Gamified Combined Cognitive Bias Modification in Adults Diagnosed With OCD: Randomized Controlled Trial

Launched by DOKUZ EYLUL UNIVERSITY · Apr 16, 2025

Keywords

ClinConnect Summary

This clinical trial is studying a new way to help people with Obsessive-Compulsive Disorder (OCD) using a mobile app. The researchers want to see if a fun, game-like approach to a technique called cognitive bias modification (CBM) can improve OCD symptoms, beliefs related to OCD, and overall mental well-being. Participants will be divided into three groups: one group will use the gamified app, another will use a standard version of the app, and the last group will use a placebo version. The study will assess participants at the start, after four weeks, and again three months later to see how well the different approaches work.

To participate, individuals must be at least 18 years old and have a confirmed diagnosis of OCD. They should have stable mental health with no recent changes in medication, and they must not be experiencing suicidal thoughts or serious mental health issues. Participants will need access to the internet and a mobile phone, and they should be able to see colored visuals clearly. This study is not yet recruiting, but it's an exciting opportunity for those looking for new ways to manage their OCD symptoms with the help of technology.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age 18 years or older
• • Primary diagnosis of obsessive-compulsive disorder (OCD), confirmed by a licensed clinician using the Structured Clinical Interview for DSM-5 (SCID-5)
• • No current suicidal ideation or psychotic symptoms
• • Access to the internet and a mobile phone
• • Stable psychiatric medication use for at least one month prior to enrollment, with no changes in dosage during the 4-week intervention period
• • No current neurological or medical condition that would interfere with participation
• • Ability to perceive colored visual stimuli (e.g., no color blindness)
• • Not currently enrolled in another intervention-based study
• • Not receiving any other form of psychological treatment at the time of participation
• Exclusion Criteria:
• • Presence of active suicidal ideation or psychotic symptoms
• • Unstable psychiatric medication use (e.g., recent dose change within the past month or expected change during the intervention period)
• • Significant neurological or medical illness that may interfere with participation
• • Visual impairments that would prevent accurate perception of colored stimuli (e.g., color blindness)
• • Current participation in another clinical trial involving psychological intervention
• • Receiving concurrent psychotherapy or other psychological treatments outside of the study